ãã€ãªå»è¬åäŒæ¥ã§ãã Trevena, Inc. ã¯ãäžæ¢ç¥çµç³»çŸæ£ã«çœ¹æ£ããæ£è
ã®ããã®æ°è¬ã®éçºãšåååã«æ³šåããŠããŸããäž»ãªè£œååè£ã«ã¯ãäžç床ããéåºŠã®æ¥æ§çŒçã®ç®¡çãç®çãšãã G ã¿ã³ãã¯è³ªååæ§ ÎŒ ãªããªã€ãåå®¹äœ (MOR) ãªã¬ã³ãã§ãã OLINVYK (ãªãªã»ãªãžã³) 泚å°å€ãCOVID-19 æ£è
ã®æ¥æ§åŒåžçª®è¿«çå矀ããã³ç°åžžãªè¡æ¶²ååºã«å¯äžããæ¥æ§èºæå·ã®æ²»çè¬ã§ãã TRV027ãæ¥æ§çé çã®æ²»çãç®çãšãã第 I çžèšåºè©Šéšãå®äºãã G ã¿ã³ãã¯è³ªååæ§ ÎŽ ãªããªã€ãå容äœäœåè¬ã§ãã TRV250ãäžç床ããéåºŠã®æ¥æ§ããã³æ
¢æ§çŒçã®æ²»çãç®çãšãã第 I çžèšåºè©Šéšãå®äºãã MOR ã®å°åå G ã¿ã³ãã¯è³ªååæ§ãªã¬ã³ãã§ãã TRV734ãããã³æ
¢æ§çŒçã管çããããã®æ°ãã S1P 調ç¯è¬ã§ãã TRV045 ããããŸããå瀟ã¯ãCOVID-19æ£è
ã察象ã«Trv027ãè©äŸ¡ãããããã€ã³ããªã¢ã«ã»ã«ã¬ããžã»ãã³ãã³ãšææºããŠããããã¬ãã瀟ã¯2007幎ã«èšç«ããããã³ã·ã«ããã¢å·ãã§ã¹ã¿ãŒãã«ãã¯ã«æ¬ç€Ÿã眮ããŠããã